Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BRETT ANDREW KING

Allopathic & Osteopathic Physicians Dermatology

NPI
1336324060
CMS profile
1113252
Location
FAIRFIELD, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$641,708.89

410 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $195,193.02 123
ABBVIE INC. $134,846.64 96
Lilly USA, LLC $89,378.32 54
Eli Lilly and Company $61,353.21 25
Incyte Corporation $55,860.20 36
Regeneron Healthcare Solutions, Inc. $46,562.71 38
GENZYME CORPORATION $42,660.68 24
Janssen Global Services, LLC $7,930.81 6
E.R. Squibb & Sons, L.L.C. $2,520.00 1
Janssen Biotech, Inc. $1,830.00 1
LEO Pharma Inc. $1,700.00 1
Merck Sharp & Dohme LLC $915.00 1
Janssen Research & Development, LLC $877.09 2
SANOFI-AVENTIS U.S. LLC $66.99 1
STRATA Skin Sciences, Inc. $14.22 1

Page 2 of 9; records 51–100 of 410 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BRETT ANDREW KING

NPI 1336324060 · CMS profile ID 1113252

Allopathic & Osteopathic Physicians / Dermatology

FAIRFIELD, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 9; records 51–100 of 410 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1336324060?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BRETT ANDREW KING, NPI 1336324060, CMS profile ID 1113252. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 410 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1336324060?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). BRETT ANDREW KING, NPI 1336324060, CMS profile ID 1113252. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 410 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1336324060?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
BRETT ANDREW KING, NPI 1336324060, CMS profile ID 1113252, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 9; records 51–100 of 410 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1336324060?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

410 matching records · $641,708.89 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 410 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 410.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $209.9811/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949654471 CMS
PFIZER INC. $3,400.0011/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949656297 CMS
PFIZER INC. $20.6411/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949538897 CMS
Eli Lilly and Company $16,975.4811/19/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917913881 CMS
Eli Lilly and Company $522.5011/19/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917915913 CMS
Eli Lilly and Company $518.0711/19/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917917045 CMS
PFIZER INC. $363.6511/18/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949655019 CMS
PFIZER INC. $8.8511/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949656749 CMS
PFIZER INC. $20.1111/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965138167 CMS
Lilly USA, LLC $3,200.0011/16/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917913897 CMS
Lilly USA, LLC $2,000.0011/16/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917917053 CMS
Lilly USA, LLC $1,600.0011/16/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917917057 CMS
ABBVIE INC. $53.7511/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893073323 CMS
Lilly USA, LLC $3,200.0011/10/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917915141 CMS
Lilly USA, LLC $2,800.0011/10/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917915927 CMS
PFIZER INC. $3,400.0011/10/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949596197 CMS
Regeneron Healthcare Solutions, Inc. $125.0011/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927235521 CMS
Regeneron Healthcare Solutions, Inc. $25.0011/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927235515 CMS
ABBVIE INC. $800.0011/08/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893073321 CMS
Incyte Corporation $4,200.0011/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943014679 CMS
PFIZER INC. $164.1611/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949655677 CMS
PFIZER INC. $3,700.0011/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949661169 CMS
ABBVIE INC. $4,000.0011/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893073319 CMS
GENZYME CORPORATION $1,464.0011/07/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939012581 CMS
Lilly USA, LLC $124.7911/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917914593 CMS
Lilly USA, LLC $1,600.0011/04/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917915137 CMS
ABBVIE INC. $1,200.0011/03/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893073313 CMS
ABBVIE INC. $7,202.0011/03/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893073315 CMS
ABBVIE INC. $14.4211/03/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893073317 CMS
Incyte Corporation $1,229.9711/03/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943014695 CMS
Incyte Corporation $2.4611/03/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943014703 CMS
ABBVIE INC. $110.9311/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893073311 CMS
PFIZER INC. $7.1111/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949607863 CMS
PFIZER INC. $262.2811/01/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949656021 CMS
PFIZER INC. $433.1011/01/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949660213 CMS
ABBVIE INC. $800.0010/26/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893073309 CMS
PFIZER INC. $438.9410/26/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949624655 CMS
ABBVIE INC. $2,400.0010/24/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893073307 CMS
PFIZER INC. $11.2810/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949477891 CMS
PFIZER INC. $133.6010/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949625153 CMS
ABBVIE INC. $7.3610/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893073305 CMS
GENZYME CORPORATION $23.3610/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939012533 CMS
Incyte Corporation $129.6910/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943014675 CMS
Incyte Corporation $676.7510/19/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943014677 CMS
GENZYME CORPORATION $8.4010/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939012539 CMS
SANOFI-AVENTIS U.S. LLC $66.9910/17/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939012527 CMS
Pfizer Inc. $850.5010/15/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048249555 CMS
Lilly USA, LLC $1,600.0010/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917917431 CMS
PFIZER INC. $2,920.0010/14/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949593171 CMS
Pfizer Inc. $4,150.0010/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048250457 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $354,281.28 228
PY2020 $186,648.81 83
PY2021 $426,673.19 152
PY2022 $641,708.89 410
PY2023 $237,636.57 137
PY2024 $232,952.51 124
PY2025 $443,510.93 201

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $12,600.00 12
PY2025 Principal investigator $216,421.60 20
PY2024 Recipient $40,581.71 26
PY2024 Principal investigator $391,311.39 28
PY2023 Recipient $27,650.00 20
PY2023 Principal investigator $569,889.15 39
PY2022 Recipient $22,617.00 21
PY2022 Principal investigator $44,893.77 18
PY2021 Recipient $6,240.00 12
PY2021 Principal investigator $320,456.46 20
PY2020 Recipient $21,944.94 9
PY2020 Principal investigator $1,109,140.22 24
PY2019 Principal investigator $950,568.41 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

32 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Sun Pharmaceutical Industries Inc. $400.00 12/24/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435790
Recipient PFIZER INC. $3,200.00 12/18/2025 Covered Recipient Physician RITLECITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228726794
Recipient PFIZER INC. $330.00 12/18/2025 Covered Recipient Physician RITLECITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228726926
Recipient PFIZER INC. $330.00 12/18/2025 Covered Recipient Physician RITLECITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228727187
Principal investigator 1 PFIZER INC. $2,074.80 12/11/2025 Non-covered Recipient Entity
Brett King MD LLC
A PHASE 3 EXTERNAL AND SYNTHETIC PLACEBOCONTROLLED RANDOMIZED STUDY WITH DOSEUP FOR NONRESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG AND 100 MG ONCE DAILY IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH ALOPECIA AREATA No dispute reported 06/30/2026 1228732256
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $51,626.25 12/04/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435784
Principal investigator 1 PFIZER INC. $17,387.35 11/26/2025 Non-covered Recipient Entity
Brett King MD LLC
A PHASE 3 EXTERNAL AND SYNTHETIC PLACEBOCONTROLLED RANDOMIZED STUDY WITH DOSEUP FOR NONRESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG AND 100 MG ONCE DAILY IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH ALOPECIA AREATA No dispute reported 06/30/2026 1228728879
Recipient PFIZER INC. $940.00 09/20/2025 Covered Recipient Physician RITLECITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228727129
Recipient PFIZER INC. $330.00 09/10/2025 Covered Recipient Physician RITLECITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228726928
Recipient PFIZER INC. $940.00 09/04/2025 Covered Recipient Physician RITLECITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228727299
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $2,028.00 08/19/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435760
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $4,225.00 08/19/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435763
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,170.00 08/19/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435767
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,875.00 08/19/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435771
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $35,802.00 08/19/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435775
Recipient PFIZER INC. $330.00 08/15/2025 Covered Recipient Physician RITLECITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228726536
Recipient PFIZER INC. $3,200.00 07/21/2025 Covered Recipient Physician RITLECITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228727029
Recipient PFIZER INC. $1,400.00 07/10/2025 Covered Recipient Physician RITLECITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228727563
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $44,547.75 05/22/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435753
Principal investigator 1 PFIZER INC. $6,146.17 05/20/2025 Non-covered Recipient Entity
Dermatology Physicians of Connecticut Fairfield
A PHASE 3 EXTERNAL AND SYNTHETIC PLACEBOCONTROLLED RANDOMIZED STUDY WITH DOSEUP FOR NONRESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG AND 100 MG ONCE DAILY IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH ALOPECIA AREATA No dispute reported 06/30/2026 1228768980
Principal investigator 1 PFIZER INC. $3,074.99 05/20/2025 Non-covered Recipient Entity
Dermatology Physicians of Connecticut Fairfield
A PHASE 3 EXTERNAL AND SYNTHETIC PLACEBOCONTROLLED RANDOMIZED STUDY WITH DOSEUP FOR NONRESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG AND 100 MG ONCE DAILY IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH ALOPECIA AREATA No dispute reported 06/30/2026 1228769139
Principal investigator 1 PFIZER INC. $915.57 05/20/2025 Non-covered Recipient Entity
Dermatology Physicians of Connecticut Fairfield
A PHASE 3 EXTERNAL AND SYNTHETIC PLACEBOCONTROLLED RANDOMIZED STUDY WITH DOSEUP FOR NONRESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG AND 100 MG ONCE DAILY IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH ALOPECIA AREATA No dispute reported 06/30/2026 1228769723
Recipient PFIZER INC. $330.00 05/07/2025 Covered Recipient Physician RITLECITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228767827
Recipient PFIZER INC. $330.00 05/06/2025 Covered Recipient Physician RITLECITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228769243
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $250.00 05/01/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435748
Principal investigator 1 Eli Lilly and Company $1,189.32 03/10/2025 Non-covered Recipient Entity
YALE UNIVERSITY
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, OPERATIONALLY SEAMLESS, ADAPTIVE PHASE 2/3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BARICITINIB IN ADULT PATIENTS WITH SEVERE OR VERY SEVERE ALOPECIA AREATA No dispute reported 06/30/2026 1187893828
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $41,909.40 02/26/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435742
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $250.00 02/22/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435738
Principal investigator 1 PFIZER INC. $962.00 02/21/2025 Non-covered Recipient Entity
Yale University
A PHASE 3 OPENLABEL MULTICENTER LONGTERM STUDY INVESTIGATING THE SAFETY AND EFFICACY OF PF06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA No dispute reported 06/30/2026 1228757401
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $250.00 02/07/2025 Non-covered Recipient Entity
Yale School Of Medicine - Yale Dermatology - Middlebury
A Multi-center, Randomized, Double-blind, Placebo-Controlled Parallel Group Phase 2 Study to Evaluate Clinical Efficacy and Safety of BMS-986165 in Participants with Alopecia Areata No dispute reported 06/30/2026 1235991600
Recipient PFIZER INC. $940.00 01/30/2025 Covered Recipient Physician ABROCITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228751786
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $338.00 01/17/2025 Non-covered Recipient Entity
Yale University
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246435733